GB1092394A - Benzomorphan derivatives and processes for their production - Google Patents

Benzomorphan derivatives and processes for their production

Info

Publication number
GB1092394A
GB1092394A GB5150064A GB5150064A GB1092394A GB 1092394 A GB1092394 A GB 1092394A GB 5150064 A GB5150064 A GB 5150064A GB 5150064 A GB5150064 A GB 5150064A GB 1092394 A GB1092394 A GB 1092394A
Authority
GB
United Kingdom
Prior art keywords
methoxyethyl
benzyl
methyl
treating
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5150064A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of GB1092394A publication Critical patent/GB1092394A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Discharge Lamp (AREA)

Abstract

The invention comprises compounds of the formula <FORM:1092394/C2/1> in which R1 represents a hydrogen atom or a hydroxy or a C1- 6 alkanoyloxy group, R2 represents a C1- 6 alkyl, b -methoxyethyl or phenyl group, R3 represents a hydrogen atom or a C1- 6 alkyl group and R4 represents a C1- 6 alkyl or phenyl group; and their preparation by reacting a compound of the formula <FORM:1092394/C2/2> in which R5 represents a hydrogen atom or a C1- 6 alkyl group, with a carbonic acid derivative of the formula halogen-COOR4 and, if desired, alkanoylating a resulting compound in which R1 is an hydroxy group, or hydrolysing a resulting compound in which R1 is an alkanoyloxy group. 2 - Methyl - 5 - (b - methoxyethyl) - 6,7 - benzomorphan and its hydrochloride are obtained by cyclization of 2-benzyl-4-(b -methoxyethyl)-1,2, 5,6-tetrahydropyridine with aluminium tribromide followed by salification. 2 - Benzyl - 4 - (b - methoxyethyl) - 1,2,5,6-tetrahydropyridine is obtained by (a) reacting 4-(b -methoxyethyl)-pyridine with methyl iodide to form 4-(b -methoxyethyl)-pyridine methiodide, treating this with sodium borohydride to form 1 - methyl - 4 - (b - methoxyethyl) - 1,2,5,6 - tetrahydropyridine, treating this with benzyl chloride to form 1-benzyl-1-methyl-4-(b -methoxyethyl)-1,2, 5,6-tetrahydropyridinium chloride and treating this with phenyl lithium, or (b) reacting 4 (b -methoxyethyl)-pyridine methiodide with benzyl magnesium chloride and treating the product with aqueous ammonium chloride to form 2-benzyl - 4 - (b - methoxyethyl) - 1 - methyl - 1,2-dihydropyridine and hydrogenating this with sodium borohydride. Pharmaceutical compositions having analgesic, antitussive and morphine antagonistic activity, for oral or parenteral administration, comprise a compound of the invention together with a pharmaceutical carrier.
GB5150064A 1963-12-20 1964-12-18 Benzomorphan derivatives and processes for their production Expired GB1092394A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
GB1092394A true GB1092394A (en) 1967-11-22

Family

ID=23297612

Family Applications (2)

Application Number Title Priority Date Filing Date
GB5149864A Expired GB1077711A (en) 1963-12-20 1964-12-18 Benzomorphans and process for their preparation
GB5150064A Expired GB1092394A (en) 1963-12-20 1964-12-18 Benzomorphan derivatives and processes for their production

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB5149864A Expired GB1077711A (en) 1963-12-20 1964-12-18 Benzomorphans and process for their preparation

Country Status (12)

Country Link
AT (4) AT249276B (en)
BE (2) BE657405A (en)
CH (7) CH446371A (en)
DE (2) DE1445853A1 (en)
DK (4) DK108497C (en)
ES (4) ES307299A1 (en)
FR (2) FR4346M (en)
GB (2) GB1077711A (en)
IL (2) IL22642A (en)
NL (3) NL6414821A (en)
NO (2) NO119273B (en)
SE (2) SE305657B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1506174B1 (en) 2002-05-17 2015-09-30 Taiwanj Pharmaceuticals Co., Ltd. Use of naltrexone for treating kidney and liver damage
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
WO2008106128A2 (en) 2007-02-26 2008-09-04 Vitae Pharmaceuticals, Inc. CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
ES2395081T3 (en) 2007-07-26 2013-02-08 Vitae Pharmaceuticals, Inc. Synthesis of 11 beta-hydroxysteroid dehydrogenase inhibitors type 1
AR069207A1 (en) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc CYCLIC UREAS AS INHIBITORS OF THE 11 BETA - HIDROXI-ESTEROIDE DESHIDROGENASA 1
EP2220048B1 (en) 2007-11-16 2017-01-25 Boehringer Ingelheim International GmbH Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
CA2712500A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009102428A2 (en) 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
EP2245014B1 (en) * 2008-02-12 2011-11-02 Boehringer Ingelheim International GmbH Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2009102460A2 (en) 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5451752B2 (en) 2008-05-01 2014-03-26 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
EP2300461B1 (en) 2008-05-01 2013-04-17 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5538365B2 (en) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
US8569292B2 (en) 2008-05-01 2013-10-29 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
RU2539979C2 (en) 2008-07-25 2015-01-27 Вайтаи Фармасьютиклз, Инк. Cyclic inhibitors of 11beta-hydroxysteroid-dehydrogenase 1
JP5777030B2 (en) 2008-07-25 2015-09-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Inhibitor of 11β-hydroxysteroid dehydrogenase 1
JP5544366B2 (en) 2008-10-23 2014-07-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Urea derivative of substituted nortropane, medicament containing the compound and use thereof
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
UA109255C2 (en) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8703765B2 (en) 2009-06-02 2014-04-22 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TWI531571B (en) 2009-11-06 2016-05-01 維它藥物公司 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
WO2011159760A1 (en) 2010-06-16 2011-12-22 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
JP5813106B2 (en) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Azaspirohexanone as an inhibitor of 11-β-HSD1 for the treatment of metabolic disorders
EP2635268A1 (en) 2010-11-02 2013-09-11 Boehringer Ingelheim International GmbH Pharmaceutical combinations for the treatment of metabolic disorders
TWI537258B (en) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
EP2744783A1 (en) 2011-08-17 2014-06-25 Boehringer Ingelheim International GmbH Indenopyridine derivatives

Also Published As

Publication number Publication date
CH449642A (en) 1968-01-15
CH449640A (en) 1968-01-15
DK106552C (en) 1967-02-20
CH449643A (en) 1968-01-15
ES307301A1 (en) 1965-05-16
AT249277B (en) 1966-09-12
FR4346M (en) 1966-08-16
NO119273B (en) 1970-04-27
ES307300A1 (en) 1965-05-01
ES307302A1 (en) 1965-05-16
DK108496C (en) 1967-12-27
CH449641A (en) 1968-01-15
BE657405A (en) 1965-06-21
AT261126B (en) 1968-04-10
NL6414821A (en) 1965-06-21
NL6414820A (en) 1965-06-21
IL22642A (en) 1968-07-25
SE305657B (en) 1968-11-04
NL127995C (en)
GB1077711A (en) 1967-08-02
CH449639A (en) 1968-01-15
NO119274B (en) 1970-04-27
AT249276B (en) 1966-09-12
IL22643A (en) 1968-07-25
CH448118A (en) 1967-12-15
SE322779B (en) 1970-04-20
AT253687B (en) 1967-04-25
DE1445854A1 (en) 1968-12-05
BE657406A (en) 1965-06-21
ES307299A1 (en) 1965-05-16
DK108497C (en) 1967-12-27
DK108495C (en) 1967-12-27
FR4345M (en) 1966-08-16
CH446371A (en) 1967-11-15
DE1445853A1 (en) 1968-12-05

Similar Documents

Publication Publication Date Title
GB1092394A (en) Benzomorphan derivatives and processes for their production
GB1014053A (en) 7-hydroxy-coumarin derivatives and process for their production
GB1060160A (en) 4-phenylpiperidine derivatives
US2824875A (en) Certificate of correction
GB1034939A (en) Isoxazole derivative and processes for its production
GB1050227A (en)
ES387016A1 (en) Isoquinoline derivatives
HU178532B (en) Process for producing 1,2,4,5-tetraalkyl-4-aryl-piperidine derivatives
GB1062714A (en) -ß-(4&#39;-acyloxy-4&#39;-piperidyl)-ketones
US3763168A (en) N-(3-quinuclidinyl) acylanilides
US3125488A (en) Method of inducing analgesia by
GB1234508A (en)
US3452026A (en) Substituted 1,2,3,4-tetrahydroquinolines
US3833595A (en) 2-aroylalkyl benzomorphans
US3629266A (en) (phenyl piperidino alkyl)3 4-dihydrocarbostyrils
US2978454A (en) Lower alkyl-4-phenyl-1-[(diloweralkoxy phenyl)-aliphatic] piperidine-4-carboxylates
DE2042504A1 (en) New derivatives of furan, thiophene and thiazole
GB822592A (en) Carbazole derivatives and process for the production thereof
KR840001161A (en) Preparation and composition of 2-cyclicamino-2- (1,2-benzisoxazol-3-yl) acetic acid ester derivatives
US4261998A (en) Tetrahydro-isoquinoline derivatives
GB1038919A (en) Quinolizine derivatives and their preparation
US3558638A (en) 3-cyano-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines
US3097208A (en) Lower alkyl 4-phenyl-1-[(aromatic nu-heteryl)-aliphatic] piperidine-4-carboxylates and their synthesis
US2485662A (en) Alpha-(aminoalkyl)-stilbenes
GB1246192A (en) Method for producing 2,6-methano-3-benzazocine derivatives